Home » Stocks » IVC

Invacare Corporation (IVC)

Stock Price: $9.28 USD 0.18 (1.92%)
Updated Mar 8, 2021 3:52 PM EST - Market open
Market Cap 313.23M
Revenue (ttm) 850.69M
Net Income (ttm) -28.28M
Shares Out 34.27M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend $0.01
Dividend Yield 0.14%
Trading Day March 8
Last Price $9.28
Previous Close $9.10
Change ($) 0.18
Change (%) 1.92%
Day's Open 9.15
Day's Range 8.95 - 9.39
Day's Volume 129,214
52-Week Range 3.89 - 10.94

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 5 days ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule f...

Business Wire - 1 week ago

ELYRIA, Ohio & OAKDALE, Pa.--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) and its subsidiary, Alber USA, LLC announced the introduction of their next generation of power assist devices – ...

Business Wire - 3 weeks ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today announced its financial results for the fourth quarter and year ended December 31, 2020. Fou...

Benzinga - 3 weeks ago

On Wednesday, February 10, Invacare (NYSE:IVC) will release its latest earnings report. Here is Benzinga's outlook for the company.

Business Wire - 1 month ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the fourth quarter and year ended Decembe...

Zacks Investment Research - 1 month ago

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

Other stocks mentioned: DGX, FMS, HSIC
Business Wire - 2 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced its conference sched...

Business Wire - 3 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE: IVC); Kathleen P. Leneghan, senior vice president and chief financi...

Business Wire - 4 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”) (NYSE: IVC) announced today the launch of the new AVIVA™ FX – MPS Maxx Multi-Position Power Standing System wheelchair, availab...

Seeking Alpha - 4 months ago

Invacare Corporation (IVC) CEO Matt Monaghan on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 4 months ago

Invacare (IVC) delivered earnings and revenue surprises of 47.37% and 3.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 4 months ago

Shares of Invacare (NYSE:IVC) fell 0.8% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 33.33% over the past year to ($0.10), whic...

Business Wire - 4 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended September 30, 2020. Key Metrics (3Q20 versus 3Q19, ex...

Business Wire - 4 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”)(NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by...

Zacks Investment Research - 4 months ago

Invacare (IVC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the third quarter ended September 30, 202...

Business Wire - 4 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (Invacare) (NYSE:IVC) announced today the introduction of an innovative and pioneering active patient lift solution for the post-acute care ...

Business Wire - 5 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Adaptive Switch Laboratories (ASL), a division of Invacare Corporation (“Invacare”)(NYSE: IVC), a leading manufacturer and distributor of medical equipment used ...

Business Wire - 5 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will present at the Lytham Partners Virtual Investor Growth Co...

Business Wire - 6 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) announced today it has retired the majority of its remaining 5% Convertible Senior Notes due 2021. The company repurchased appro...

Business Wire - 6 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”)(NYSE:IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by ...

Business Wire - 6 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule f...

Seeking Alpha - 7 months ago

Invacare's (IVC) CEO Matt Monaghan on Q2 2020 Results - Earnings Call Transcript

Business Wire - 7 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Kathleen P. Leneghan, senior vice president and chief financial officer, and Lois Lee, director, treasury, investor relations and corporate communications, of In...

Business Wire - 7 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) ("Invacare" or the "company") today reported results for the quarter ended June 30, 2020. Key Metrics (2Q20 versus 2Q19*) Report...

Zacks Investment Research - 7 months ago

Invacare (IVC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 7 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter ended June 30, 2020, a...

Business Wire - 7 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”)(NYSE:IVC) will participate on Tuesday, July 14, 2020 in the 20th Annual CJS Securities New Ideas Summer Conference where the co...

Business Wire - 7 months ago

ELYRIA, Ohio & OAKDALE, Pa.--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) and Alber®, a global leader in power-assist solutions, announced today the US introduction of SMOOV one™, an inno...

Business Wire - 8 months ago

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC)(the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that...

Zacks Investment Research - 10 months ago

Invacare (IVC) delivered earnings and revenue surprises of 30.00% and 0.20%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Invacare (IVC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 10 months ago

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Other stocks mentioned: INGN, VAPO
Seeking Alpha - 10 months ago

Madrigal's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma

Other stocks mentioned: MDGL, MRNA
The Motley Fool - 1 year ago

Investors are optimistic a turnaround will pay off in 2020.

Seeking Alpha - 1 year ago

Invacare Corporation (IVC) CEO Matthew Monaghan on Q4 2019 Results - Earnings Call Transcript

The Motley Fool - 1 year ago

These income-producing stocks could be cheap additions to your portfolio.

Other stocks mentioned: HMC, L
Seeking Alpha - 1 year ago

Invacare Corporation (IVC) CEO Matt Monaghan on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Invacare (IVC) delivered earnings and revenue surprises of 28.57% and -2.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Invacare (IVC) delivered earnings and revenue surprises of -10.71% and 0.67%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Invacare Corporation (IVC) CEO Matthew Monaghan on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Invacare (IVC) delivered earnings and revenue surprises of 0.00% and -0.79%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Invacare.

About IVC

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning prod... [Read more...]

Industry
Medical Devices
Founded
1885
CEO
Matthew Monaghan
Country
United States
Stock Exchange
NYSE
Ticker Symbol
IVC
Full Company Profile

Financial Performance

In 2020, Invacare's revenue was $850.69 million, a decrease of -8.33% compared to the previous year's $927.96 million. Losses were -$28.28 million, -46.97% less than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Invacare stock is "Buy." The 12-month stock price forecast is 16.00, which is an increase of 72.51% from the latest price.

Price Target
$16.00
(72.51% upside)
Analyst Consensus: Buy